GeoVax Labs Inc (GOVX)

[remind2]

GOVX: Phase 2 HIV vax for .08 cents a share.


Investors buying in now get a company that is the culmination of 15 years of R&D with heavy Fed support and even more on the way.

GOVX has a Phase 2 HIV vaccine that works,

GOVX has an Ebola vaccine that also works.

Based on that great track record the Feds made sure the GOVX science is included as a foundation block in the Zika vaccine hunt.

GOVX has a $3.5M $$ market cap and a 42M share float.

The share count is what one would see in a Nasdaq company and is trading at a penny stock price.

Most investors looking at GOVX from a new investor angle have to love the set up.

New investors only care what will be not what was,

GOVX has put in many years of hard R&D while the share price eroded.

Now the R&D is ripe just as the stock price is at a low.

That is a recipe for making some serious cash going forward.


LINK:Vaccine M&A.
http://www.fiercepharma.com/vaccines/vaccines-set-for-m-a-wave-serum-institute-ceo-predicts